Two strategies for prevention of cytomegalovirus infections after liver transplantation

doi:10.3748/wjg.v22.i12.3412

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 22, Issue 12

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7859)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

571

WORD

299

HTML

3148

Figures (1-1)

337

Tables (1-2)

229

Sum=4584

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1218

Download

2057

Sum=3275

Mar 28, 2016 (publication date) through Jan 10, 2025

Times Cited of This Article

Times Cited (14)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Mar 28, 2016; 22(12): 3412-3417
Published online Mar 28, 2016. doi: 10.3748/wjg.v22.i12.3412

Table 1 Patient demographics n (%)

	All (n = 128)	Prophylaxis (n = 60)	Preemptive therapy (n = 68)	P value
Age (yr)	54 ± 10	52 ± 12	56 ± 8.5	0.04
Sex
Male	90 (70)	42 (70)	48 (71)	1.00
Female	38 (30)	18 (30)	20 (29)
Weight (kg)	80 ± 16	81 ± 13	79 ± 19	0.52
SOFA	9.1 ± 4.0	8.8 ± 3.8	9.4 ± 4.3	0.34
APACHE II	14.2 ± 6.7	13.3 ± 5.5	15.0 ± 7.5	0.13
Lab. MELD at Transplantation	18.5 ± 9.4	18.8 ± 8.8	18.2 ± 9.9	0.73
CMV-status D/R				0.24
-/-	19 (17)	5 (10)	14 (22)
-/+	33 (29)	16 (33)	17 (27)
+/+	60 (54)	28 (57)	32 (51)
+/-	Excluded

Data are expressed as mean ± SD or n (%). Complete CMV-status was unavailable for 16 patients, but was known not to be +/-. D/R: Donor/receptor; CMV: Cytomegalovirus; Lab.MELD: Model of end stage liver disease.

Citation: Simon P, Sasse M, Laudi S, Petroff D, Bartels M, Kaisers UX, Bercker S. Two strategies for prevention of cytomegalovirus infections after liver transplantation. World J Gastroenterol 2016; 22(12): 3412-3417
URL: https://www.wjgnet.com/1007-9327/full/v22/i12/3412.htm
DOI: https://dx.doi.org/10.3748/wjg.v22.i12.3412